StatSure Diagnostic Systems, Inc. (SSUR)
- Previous Close
0.0002 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0002 - 0.0002 - Volume
1 - Avg. Volume
0 - Market Cap (intraday)
107,057 - Beta (5Y Monthly) -1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices. The company was founded in 1986 and is based in Brooklyn, New York.
www.statsurediagnostics.comRelated News
Performance Overview: SSUR
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SSUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SSUR
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
1.45
Enterprise Value/EBITDA
-2.20
Financial Highlights
Profitability and Income Statement
Profit Margin
39.32%
Return on Assets (ttm)
-114.48%
Return on Equity (ttm)
--
Revenue (ttm)
1M
Net Income Avi to Common (ttm)
235.06k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
100.16k
Company Insights: SSUR
SSUR does not have Company Insights